German BioNTech misses Q2 profit and revenue forecasts, shares underperform

nl.investing.com (Dutch)

BioNTech reported second-quarter results missing expectations: a loss per share of €3.24 on revenue of €105.6 million, causing shares to underperform. Analysts polled by Investing.com expected a loss per share of €2.03 and revenue of €163.27 million. BioNTech's actual figures fell substantially short of those consensus estimates. BioNTech shares are down 4% year-to-date, underperforming the Nasdaq's 14% gain. This month, J&J beat Q2 forecasts while AbbVie missed on profit.


With a significance score of 1.1, this news ranks in the top 52% of today's 33212 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


German BioNTech misses Q2 profit and revenue forecasts, shares underperform | News Minimalist